Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...

The highly anticipated presentation will be delivered by Francisco Silva, Vice President of Research and Development at ...

China Medical University Hospital (Taiwan) and Shine-On Biomedical Co. developed SOB100, the world's first HLA-G targeted ...

A groundbreaking telehealth trial offers remote access to innovative pancreatic cancer treatment, enhancing patient ...

A migraine drug commonly used to treat headache pain may also alleviate the early, non-pain symptoms that often precede a ...

MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...

LOS ANGELES, June 9, 2025 /PRNewswire/ — TORL BioTherapeutics LLC (TORL), a clinical-stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the ...

Humacyte markets Symvess for the treatment of extremity vascular trauma. Read why HUMA stock is a Sell but can see its ...

An experimental drug empowered by artificial intelligence to identify a novel therapeutic target for a severe lung disease ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

While the company is showing early signs of recovery and margin improvement, a high valuation means risks remain.